Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1327

Bifidobacterium breve GDMCC 62945

Intended Use: Intended for use as an ingredient in non-exempt infant formula for term infants at 1 x 108 colony forming units (CFU)/g and in conventional food at levels up to 5 x 1010 CFU/serving (excluding use in products under the jurisdiction of the United States Department of Agriculture (USDA)).
Basis: Scientific procedures
Notifier: Jiangsu New-Bio Biotechnology Co., LTD
Notifier Address: Legal & Operative Office
28 Keda Road
Jiangyin City, Jiangsu Province
CHINA
GRAS Notice (releasable information): GRN 1327 (in PDF) (1.6 MB)
FDA's Letter: Pending
-
-